Please login to the form below

Not currently logged in
Email:
Password:

FDA approves Teva's Alzheimer's drug

The US Food and Drug Administration has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept

The US Food and Drug Administration (FDA) has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept (donepezil).

Teva said that it has already begun shipping the product, in 5mg and 10mg tablets.

Aricept has been the market leader among drugs that alleviate symptoms of Alzheimer's disease, such as memory problems, confusion and aggression.

Annual sales of the drug in the US are believed to be $2.3 bn.

Meanwhile Teva has declined to comment on media reports that its president and chief executive Shlomo Yanai flew to India several days ago to discuss potential collaborations with Indian pharmaceutical companies.

2nd June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics